Alterations in BDNF and phospho-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice

Neuroscience Letters

Volumn 491, Issue 2, 2011, Pages 108-112

  Kivinummi, Tanja ^a   Kaste, Kristiina ^a   Rantamäki, Tomi ^a   Castrén, Eero ^a   Ahtee, Liisa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

BDNF; Nicotine; PCREB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NICOTINE; PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; MALE; MOUSE; NERVE CELL PLASTICITY; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SMOKING CESSATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ADMINISTRATION, ORAL; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEURONAL PLASTICITY; NICOTINE; NICOTINIC AGONISTS; PHOSPHORYLATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 79951578544     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.01.015     Document Type: Article

References (48)

1. Aleisa A.M., Alzoubi K.H., Gerges N.Z., Alkadhi K.A. Chronic psychosocial stress-induced impairment of hippocampal LTP: possible role of BDNF. Neurobiol. Dis. 2006, 22:453-462.
2. Bhang S.Y., Choi S.W., Ahn J.H. Changes in plasma brain-derived neurotrophic factor levels in smokers after smoking cessation. Neurosci. Lett. 2010, 468:7-11.
3. Bisset G.W., Walker J.M. The effects of nicotine, hexamethonium and ethanol on the secretion of the antidiuretic and oxytocic hormones of the rat. Brit. J. Pharmacol. Chemother. 1957, 12:461-467.
4. Brown R.W., Perna M.K., Schaefer T.L., Williams M.T. The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole. Synapse 2006, 59:253-259.
5. Brunzell D.H., Russell D.S., Picciotto M.R. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J. Neurochem. 2003, 84:1431-1441.
6. Carlezon W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., Nestler E.J. Regulation of cocaine reward by CREB. Science 1998, 282:2272-2275.
7. Correll J.A., Noel D.M., Sheppard A.B., Thompson K.N., Li Y., Yin D., Brown R.W. Nicotine sensitization and analysis of brain-derived neurotrophic factor in adolescent beta-arrestin-2 knockout mice. Synapse 2009, 63:510-519.
8. Czubak A., Nowakowska E., Kus K., Burda K., Metelska J., Baer-Dubowska W., Cichocki M. Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacol. Rep. 2009, 61:1017-1023.
9. Dong Y., Green T., Saal D., Marie H., Neve R., Nestler E.J., Malenka R.C. CREB modulates excitability of nucleus accumbens neurons. Nat. Neurosci. 2006, 9:475-477.
10. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic coordinates 1997, Academic Press, Inc., San Diego (CA), USA.
11. Gäddnäs H., Pietilä K., Ahtee L. Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice. Behav. Brain Res. 2000, 113:65-72.
12. Gäddnäs H., Piepponen T.P., Ahtee L. Mecamylamine decreases accumbal dopamine output in mice treated chronically with nicotine. Neurosci. Lett. 2002, 330:219-222.
13. Gerdeman G.L., Partridge J.G., Lupica C.R., Lovinger D.M. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 2003, 26:184-192.
14. Ghitza U.E., Zhai H., Wu P., Airavaara M., Shaham Y., Lu L. Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci. Biobehav. Rev. 2009.
15. Graham D.L., Edwards S., Bachtell R.K., DiLeone R.J., Rios M., Self D.W. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat. Neurosci. 2007, 10:1029-1037.
16. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 2003, 23:742-747.
17. Hunt W.A., Barnett L.W., Branch L.G. Relapse rates in addiction programs. J. Clin. Psychol. 1971, 27:455-456.
18. Janhunen S., Ahtee L. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neurosci. Biobehav. Rev. 2007, 31:287-314.
19. Karpova N.N., Rantamaki T., Di Lieto A., Lindemann L., Hoener M.C., Castren E. Darkness reduces BDNF expression in the visual cortex and induces repressive chromatin remodeling at the BDNF gene in both hippocampus and visual cortex. Cell. Mol. Neurobiol. 2010, 30:1117-1123.
20. Kaste K., Kivinummi T., Piepponen T.P., Kiianmaa K., Ahtee L. Differences in basal and morphine-induced FosB/DeltaFosB and pCREB immunoreactivities in dopaminergic brain regions of alcohol-preferring AA and alcohol-avoiding ANA rats. Pharmacol. Biochem. Behav. 2009, 92:655-662.
21. Kenny P.J., File S.E., Rattray M. Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res. Mol. Brain Res. 2000, 85:234-238.
22. Kim T.S., Kim D.J., Lee H., Kim Y.K. Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neurosci. Lett. 2007, 423:53-57.
23. Lipsky R.H., Marini A.M. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann. N.Y. Acad. Sci. 2007, 1122:130-143.
24. Lu L., Dempsey J., Liu S.Y., Bossert J.M., Shaham Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J. Neurosci. 2004, 24:1604-1611.
25. Maggio R., Riva M., Vaglini F., Fornai F., Racagni G., Corsini G.U. Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. J. Neural Transm. 1997, 104:1113-1123.
26. Marco E.M., Granstrem O., Moreno E., Llorente R., Adriani W., Laviola G., Viveros M.P. Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats. Eur. J. Pharmacol. 2007, 557:37-43.
27. Marttila K., Raattamaa H., Ahtee L. Effects of chronic nicotine administration and its withdrawal on striatal FosB/DeltaFosB and c-Fos expression in rats and mice. Neuropharmacology 2006, 51:44-51.
28. Mayr B., Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2001, 2:599-609.
29. McClung C.A., Nestler E.J. Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 2008, 33:3-17.
30. McDaid J., Dallimore J.E., Mackie A.R., Napier T.C. Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum. Neuropsychopharmacology 2006, 31:1212-1226.
31. Nuutinen S., Ahtee L., Tuominen R.K. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice. Eur. J. Pharmacol. 2005, 515:83-89.
32. Olson V.G., Zabetian C.P., Bolanos C.A., Edwards S., Barrot M., Eisch A.J., Hughes T., Self D.W., Neve R.L., Nestler E.J. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J. Neurosci. 2005, 25:5553-5562.
33. Olson V.G., Green T.A., Neve R.L., Nestler E.J. Regulation of morphine reward and feeding by CREB in the lateral hypothalamus. Synapse 2007, 61:110-113.
34. Pekonen K., Karlsson C., Laakso I., Ahtee L. Plasma nicotine and cotinine concentrations after chronic oral nicotine administration and challenge doses. Eur. J. Pharm. Sci. 1993, 1:13-18.
35. Pietilä K., Ahtee L. Chronic nicotine administration in the drinking water affects the striatal dopamine in mice. Pharmacol. Biochem. Behav. 2000, 66:95-103.
36. Pietilä K., Laakso I., Ahtee L. Chronic oral nicotine administration affects the circadian rhythm of dopamine and 5-hydroxytryptamine metabolism in the striata of mice, Naunyn Schmiedebergs. Arch. Pharmacol. 1995, 353:110-115.
37. Pietilä K., Lähde T., Attila M., Ahtee L., Nordberg A. Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment, Naunyn Schmiedebergs. Arch. Pharmacol. 1998, 357:176-182.
38. Srivareerat M., Tran T.T., Salim S., Aleisa A.M., Alkadhi K.A. Chronic nicotine restores normal Abeta levels and prevents short-term memory and E-LTP impairment in Abeta rat model of Alzheimer's disease. Neurobiol. Aging 2009.
39. Tammimäki A., Pietilä K., Raattamaa H., Ahtee L. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice. Eur. J. Pharmacol. 2006, 531:118-125.
40. Tammimäki A., Chistyakov V., Patkina N., Skippari J., Ahtee L., Zvartau E., Männistö P.T. Effect of forced chronic oral nicotine exposure on intravenous self-administration and rewarding properties of acute nicotine. Eur. J. Pharmacol. 2008, 591:164-170.
41. Vieyra-Reyes P., Picciotto M.R., Mineur Y.S. Voluntary oral nicotine intake in mice down-regulates GluR2 but does not modulate depression-like behaviors. Neurosci. Lett. 2008, 434:18-22.
42. Vihavainen T., Mijatovic J., Piepponen T.P., Tuominen R.K., Ahtee L. Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice. Behav. Brain Res. 2006, 173:85-93.
43. Vihavainen T., Piltonen M., Tuominen R.K., Korpi E.R., Ahtee L. Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure. Eur. J. Pharmacol. 2008, 587:169-174.
44. Walters C.L., Kuo Y.C., Blendy J.A. Differential distribution of CREB in the mesolimbic dopamine reward pathway. J. Neurochem. 2003, 87:1237-1244.
45. Walters C.L., Godfrey M., Li X., Blendy J.A. Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice. Brain Res. 2005, 1032:193-199.
46. Walters C.L, Cleck J.N., Kuo Y.C., Blendy J.A. μ-Opioid receptor and CREB activation are required for nicotine reward. Neuron 2005, 46:933-943.
47. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 2002, 36:229-240.
48. Yeom M., Shim I., Lee H.J., Hahm D.H. Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem. Biophys. Res. Commun. 2005, 326:321-328.